AC

Angela Cacace

FT Fulcrum Therapeutics: 2 patents #1 of 8Top 15%
BS Bristol-Myers Squibb: 2 patents #52 of 557Top 10%
RA Roche Innovation Center Copenhagen A/S: 1 patents #3 of 13Top 25%
📍 Haddam Neck, CT: #1 of 1 inventorsTop 100%
🗺 Connecticut: #255 of 3,820 inventorsTop 7%
Overall (2022): #53,298 of 548,613Top 10%
4
Patents 2022

Issued Patents 2022

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
11479770 Use of p38 inhibitors to reduce expression of DUX4 Luis Gustavo Alejandro Rojas Soto, Lorin A. Thompson, III, Owen Brendan Wallace, Lucienne V. Ronco, Ning Shen +2 more 2022-10-25
11447775 Antisense oligonucleotides targeting alpha-synuclein and uses thereof Richard E. Olson, Jere E. Meredith, Nino Devidze, James K. Loy, Carl J. Baldick +4 more 2022-09-20
11359197 Antisense oligonucleotides targeting alpha-synuclein and uses thereof Richard E. Olson, Jere E. Meredith, Nino Devidze, James K. Loy, Carl J. Baldick +4 more 2022-06-14
11291659 P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD Luis Gustavo Alejandro Rojas Soto, Lorin A. Thompson, III, Owen Brendan Wallace, Lucienne V. Ronco, Ning Shen +2 more 2022-04-05